Pharmafile Logo
Pharmafocus logo
Advanced Search

GSK buys more of Theravance

May 18, 2012
Research and Development, Sales and Marketing COPD, Cellzome, GSK, Relovair, Theravance

GlaxoSmithKline now owns more than a quarter of biopharma company Theravance after shelling out nearly $213 million to buy ten …

News

OPEN Health invests in Harvey Walsh

May 18, 2012
Medical Communications Harvey Walsh, Open Health

Harvey Walsh, a market access and healthcare intelligence company, is to join forces with OPEN Health, the healthcare communications group.  OPEN Health …

News
screen_shot_2012-05-18_at_09

Teva re-elects Chairman of the Board

May 18, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Frost, Teva

Teva has announced that its Board of Directors has unanimously voted to re-elect Dr Phillip Frost as Chairman of the …

Appointment

Plavix loses US patent protection

May 18, 2012
Sales and Marketing BMS, FDA, Lipitor, Pfizer, Plavix, Sanofi

Sanofi and Bristol-Myers Squibb’s blood thinner Plavix has lost its patent protection in the US.  The drug, which made $6.6 …

News
Andrew Lansley

NICE to be sidelined on cost effectiveness – once again

May 17, 2012
Sales and Marketing NICE, VBP

Health secretary Andrew Lansley has confirmed that NICE will no longer direct the NHS on the cost effectiveness of drugs. …

News
NICE image

NICE comes out fighting against appraisal delays story

May 17, 2012
Sales and Marketing Daily Mail, Dillon, NHS, NICE, Pfizer, Victrelis

NICE has criticised a report that says the watchdog has taken up to nine years to appraise certain drugs.   The …

News

Medivir appoints commercial executive vice president

May 17, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Juserius, Medivir

Research-based speciality firm Medivir has appointed Henric Juserius to be the new head of the company’s commercial activities.  Juserius who …

Appointment
Nexavar image

Torisel fails in head-to-head study with Nexavar

May 16, 2012
Research and Development, Sales and Marketing Bayer, Nexavar, Pfizer, Torisel, inlyta, rcc

Pfizer’s kidney cancer drug Torisel has failed to best Bayer’s Nexavar in a head-to-head trial.  The Phase III study was …

News

Pharma funds drug discovery partnership

May 16, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Dundee, MRC, drug discovery, funding, partnerships, pharma

Half a dozen pharma firms are contributing £14.4 million to work by Dundee University and the Medical Research Council (MRC) on …

News
Erbitux image

Merck KGaA’s colon cancer drug fails trial

May 16, 2012
Research and Development, Sales and Marketing Erbitux, Merck KGaA, Merck Serono, colon cancer

Merck KGaA has suffered a setback with key brand Erbitux as the colerectal cancer drug failed in a late-stage trial.  …

News

Capturing the Brazilian pharma opportunity

May 16, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Brazil, McKinsey, market access, middle class, pharma

 Many multinationals are hungry to sell their goods and services to the emerging markets’ growing middle class, comprising nearly two …

Feature
Zytiga image

Price cut sways NICE on Zytiga

May 16, 2012
Sales and Marketing Jevtana, NICE, Zytiga, prostate cancer

NICE is recommending Janssen’s prostate cancer pill Zytiga, reversing its previous stance.  In its final guidance, the watchdog is recommending …

News

Open Health appoints new digital designer

May 16, 2012
Business Services, Medical Communications, Sales and Marketing Open Health

Leo Jacobs has been appointed by Open Health as a digital designer to sit within its OPEN Source team. The …

Appointment

Merck KGaA sets out savings target as staff threaten to strike

May 15, 2012
Research and Development, Sales and Marketing Merck KGaA, R&D, Serono, cuts

Merck KGaA has outlined its plan to make €300 million in savings from its Serono drugs unit, with over half …

News

CoreLab Partners collaborates at industry conferences worldwide

May 15, 2012
Research and Development

Princeton, NJ May 15, 2012 – CoreLab Partners, Inc, a leading independent core lab providing centralized cardiac safety services and …

News
Press release

Genentech taken to task over Avastin production

May 15, 2012
Manufacturing and Production Genentech, Phil Taylor, avastin, manufacturing

FDA inspections of a manufacturing facility for Roche/Genentech’s cancer drug Avastin (bevacizumab) uncovered a number of deficiencies which could increase …

News
abpi image

ABPI launches new NHS partnership guide

May 15, 2012
Medical Communications, Sales and Marketing ABPI, COPD, NHS, code

The Association of the British Pharmaceutical Industry has launched a new guide to explain how pharma and the NHS can …

News
GSK picture

GlaxoSmithKline to acquire Cellzome for £61 million

May 15, 2012
Research and Development, Sales and Marketing Cellzome, Domantis, GSK, R&D

GlaxoSmithKline will expand its platform technology capability with the acquisition of a chemical proteomics company.  GSK will acquire those shares …

News

Synthetic Biologics appoints Carol Reed

May 15, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Carol Reed, Synthetic

Synthetic Biologics has appointed Carol Reed as senior vice president of Clinical & Regulatory Affairs. In this position Reed will …

Appointment
Gilenya image

Gilenya to stay on US market – but with new safety warnings

May 15, 2012
Sales and Marketing EMA, FDA, Novartis, PML, gilenya

The FDA says that Novartis’ multiple sclerosis pill Gilenya should stay on the market, but has added new safety warnings …

News
The Gateway to Local Adoption Series

Latest content

Five Facts about the menopause

March 6, 2026

Zello Appoints Kevin Bailey as Group Chief Medical Officer

March 6, 2026

BioDuro establishes joint manufacturing venture with Cenra

March 6, 2026

Symbiosis appoints Joanne Anderson as Chief Commercial Officer

March 6, 2026

Secarna Pharmaceuticals and Curie.Bio expand existing partnership

March 6, 2026